Sale!

Cancer Breast Comprehensive Panel Test Cost

Original price was: 1,820 د.إ.Current price is: 1,640 د.إ.

-10%

The “Cancer Breast Comprehensive Panel Test” is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to provide a thorough analysis of genetic markers associated with breast cancer. This panel test is an integral part of preventive health care for individuals at risk of developing breast cancer, offering insights into genetic predispositions and mutations that may influence the development of the disease. Priced at 1640 AED, the test is conducted in a state-of-the-art facility, ensuring accuracy and reliability in results. By analyzing specific genes known to be linked with breast cancer, this comprehensive panel helps in early detection and facilitates personalized treatment plans, significantly improving the chances of successful management and outcomes.

Description

Cancer Breast Comprehensive Panel Test

Test Name: Cancer Breast Comprehensive Panel Test

Test Components:

IHC ERBB2 (HER-2) with reflex to FISH
ER
PR
Ki67

Price: 1640.0 AED

Sample Condition: Submit tumor tissue in 10% Formalin OR Formalin fixed paraffin embedded tissue block. Ship at room temperature. Provide a copy of the Histopathology report, clinical history & indicate site of biopsy.

Report Delivery: Sample due by Tuesday 9 am; Report available in 10 working days

Method: Immunohistochemistry, FISH

Test Type: Breast Cancer

Doctor: Oncologist

Test Department: Cytogenetics

Pre Test Information: Provide a copy of the Histopathology report, clinical history & indicate site of biopsy.

Test Details:

The Cancer Breast Comprehensive Panel test is a diagnostic test used to assess the risk of breast cancer in individuals. It analyzes multiple genes associated with breast cancer to identify any genetic mutations or variations that may increase the risk of developing the disease.

The test typically includes the analysis of genes such as BRCA1 and BRCA2, which are known to be associated with an increased risk of breast and ovarian cancers. Other genes that may be included in the panel depend on the specific laboratory conducting the test.

The test is usually recommended for individuals with a personal or family history of breast cancer, especially if they have multiple relatives affected by the disease or if the cancer occurred at an early age. It can also be used to determine the likelihood of developing breast cancer in individuals who have already been diagnosed with the disease.

The Cancer Breast Comprehensive Panel test is typically performed using a blood sample or a saliva sample, which is then sent to a specialized laboratory for analysis. The results of the test can help individuals and their healthcare providers make informed decisions about their healthcare, such as considering preventive measures or personalized treatment options.

It’s important to note that the test does not provide a definitive diagnosis of breast cancer, but rather assesses the risk of developing the disease based on genetic factors. It is usually used in conjunction with other diagnostic tools and medical evaluations to provide a comprehensive assessment of an individual’s breast cancer risk.

Test Name	CANCER BREAST COMPREHENSIVE PANEL Test
Components	IHC ERBB2 (HER-2) with reflex to FISHER PRKi67
Price	1640.0 AED
Sample Condition	Submit tumor tissue in 10% Formalin OR Formalin fixed paraffin embedded tissue block. Ship at room temperature. Provide a copy of the Histopathologyreport,clinical history & indicate site of biopsy.
Report Delivery	SampleTue by 9 am; Report 10 Working days
Method	Immunohistochemistry, FISH
Test type	Breast Cancer
Doctor	Oncologist
Test Department:	CYTOGENETICS
Pre Test Information	Provide a copy of the Histopathologyreport,clinical history & indicate site of biopsy.
Test Details	The Cancer Breast Comprehensive Panel test is a diagnostic test used to assess the risk of breast cancer in individuals. It analyzes multiple genes associated with breast cancer to identify any genetic mutations or variations that may increase the risk of developing the disease. The test typically includes the analysis of genes such as BRCA1 and BRCA2, which are known to be associated with an increased risk of breast and ovarian cancers. Other genes that may be included in the panel depend on the specific laboratory conducting the test. The test is usually recommended for individuals with a personal or family history of breast cancer, especially if they have multiple relatives affected by the disease or if the cancer occurred at an early age. It can also be used to determine the likelihood of developing breast cancer in individuals who have already been diagnosed with the disease. The Cancer Breast Comprehensive Panel test is typically performed using a blood sample or a saliva sample, which is then sent to a specialized laboratory for analysis. The results of the test can help individuals and their healthcare providers make informed decisions about their healthcare, such as considering preventive measures or personalized treatment options. It’s important to note that the test does not provide a definitive diagnosis of breast cancer, but rather assesses the risk of developing the disease based on genetic factors. It is usually used in conjunction with other diagnostic tools and medical evaluations to provide a comprehensive assessment of an individual’s breast cancer risk.